Odontoprev (ODPV3.SA) Stock Price
Odontoprev Price
Revenue has compounded at 14.4% per year over the past 19 years to 2.42 B BRL. Earnings per share have grown at 9.5% per year over the last 16 years. Odontoprev's net margin stands at 24.1%, up from 20.6% several years earlier. Odontoprev currently offers a dividend yield of about 6.58%. The payout ratio is around 90% of earnings. The dividend has grown at 1.7% per year over the past 18 years. Analysts set a median price target of 13.26 BRL, implying 9.3% below the current price. Of 17 analysts, 1 rate the stock a buy — an overall Sell consensus. The stock trades about 36% above its 52-week low.
Odontoprev stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Odontoprev over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Odontoprev stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Odontoprev's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Odontoprev Price |
|---|---|
| 7/3/2026 | 14.62 BRL |
| 7/2/2026 | 14.41 BRL |
| 7/1/2026 | 14.25 BRL |
| 6/30/2026 | 14.38 BRL |
| 6/29/2026 | 14.46 BRL |
| 6/26/2026 | 14.28 BRL |
| 6/25/2026 | 14.00 BRL |
| 6/24/2026 | 13.90 BRL |
| 6/23/2026 | 13.81 BRL |
| 6/22/2026 | 13.64 BRL |
| 6/19/2026 | 13.40 BRL |
| 6/18/2026 | 12.94 BRL |
| 6/17/2026 | 12.76 BRL |
| 6/16/2026 | 12.85 BRL |
| 6/15/2026 | 12.94 BRL |
| 6/12/2026 | 13.15 BRL |
| 6/11/2026 | 13.00 BRL |
| 6/10/2026 | 12.84 BRL |
| 6/9/2026 | 13.07 BRL |
| 6/8/2026 | 12.57 BRL |
| 6/5/2026 | 12.59 BRL |
| 6/3/2026 | 12.78 BRL |
| 6/2/2026 | 13.28 BRL |
| 6/1/2026 | 13.40 BRL |
| 5/29/2026 | 13.56 BRL |
| 5/28/2026 | 13.69 BRL |
| 5/27/2026 | 13.80 BRL |
| 5/26/2026 | 13.79 BRL |
| 5/25/2026 | 13.44 BRL |
| 5/22/2026 | 12.89 BRL |
| 5/21/2026 | 13.30 BRL |
| 5/20/2026 | 13.35 BRL |
| 5/19/2026 | 13.39 BRL |
| 5/18/2026 | 13.61 BRL |
| 5/15/2026 | 13.75 BRL |
| 5/14/2026 | 13.88 BRL |
| 5/13/2026 | 13.90 BRL |
| 5/12/2026 | 14.38 BRL |
| 5/11/2026 | 14.42 BRL |
| 5/8/2026 | 15.17 BRL |
| 5/7/2026 | 14.76 BRL |
| 5/6/2026 | 15.64 BRL |
| 5/5/2026 | 15.93 BRL |
| 5/4/2026 | 15.02 BRL |
| 4/30/2026 | 15.25 BRL |
| 4/29/2026 | 14.73 BRL |
| 4/28/2026 | 14.59 BRL |
| 4/27/2026 | 14.70 BRL |
| 4/24/2026 | 14.89 BRL |
| 4/23/2026 | 15.16 BRL |
| 4/22/2026 | 15.40 BRL |
| 4/20/2026 | 15.60 BRL |
| 4/17/2026 | 15.78 BRL |
| 4/16/2026 | 15.80 BRL |
| 4/15/2026 | 15.83 BRL |
| 4/14/2026 | 15.96 BRL |
| 4/13/2026 | 15.92 BRL |
| 4/10/2026 | 15.48 BRL |
| 4/9/2026 | 15.21 BRL |
| 4/8/2026 | 14.50 BRL |
| 4/7/2026 | 14.09 BRL |
| 4/6/2026 | 13.73 BRL |
| 4/2/2026 | 13.74 BRL |
| 4/1/2026 | 13.74 BRL |
| 3/31/2026 | 13.43 BRL |
| 3/30/2026 | 13.23 BRL |
| 3/27/2026 | 13.28 BRL |
| 3/26/2026 | 13.40 BRL |
| 3/25/2026 | 13.55 BRL |
| 3/24/2026 | 13.28 BRL |
| 3/23/2026 | 13.30 BRL |
| 3/20/2026 | 13.00 BRL |
| 3/19/2026 | 13.27 BRL |
| 3/18/2026 | 13.10 BRL |
| 3/17/2026 | 13.27 BRL |
| 3/16/2026 | 13.21 BRL |
| 3/13/2026 | 13.20 BRL |
| 3/12/2026 | 13.38 BRL |
| 3/11/2026 | 13.98 BRL |
| 3/10/2026 | 13.87 BRL |
| 3/9/2026 | 13.71 BRL |
| 3/6/2026 | 13.70 BRL |
| 3/5/2026 | 13.73 BRL |
| 3/4/2026 | 13.76 BRL |
| 3/3/2026 | 13.51 BRL |
| 3/2/2026 | 13.72 BRL |
| 2/27/2026 | 14.64 BRL |
| 2/26/2026 | 12.85 BRL |
| 2/25/2026 | 12.55 BRL |
| 2/24/2026 | 12.61 BRL |
| 2/23/2026 | 12.24 BRL |
| 2/20/2026 | 12.25 BRL |
| 2/19/2026 | 12.39 BRL |
| 2/18/2026 | 12.08 BRL |
| 2/13/2026 | 11.87 BRL |
| 2/12/2026 | 11.95 BRL |
| 2/11/2026 | 12.00 BRL |
| 2/10/2026 | 11.91 BRL |
| 2/9/2026 | 11.85 BRL |
| 2/6/2026 | 11.87 BRL |
| 2/5/2026 | 11.93 BRL |
| 2/4/2026 | 11.94 BRL |
| 2/3/2026 | 12.17 BRL |
| 2/2/2026 | 12.12 BRL |
| 1/30/2026 | 11.31 BRL |
| 1/29/2026 | 11.39 BRL |
| 1/28/2026 | 11.37 BRL |
| 1/27/2026 | 11.25 BRL |
| 1/26/2026 | 11.32 BRL |
| 1/23/2026 | 11.35 BRL |
| 1/22/2026 | 11.30 BRL |
| 1/21/2026 | 11.11 BRL |
| 1/20/2026 | 10.84 BRL |
| 1/19/2026 | 10.78 BRL |
| 12/17/2025 | 11.15 BRL |
| 12/16/2025 | 11.44 BRL |
| 12/15/2025 | 11.59 BRL |
| 12/12/2025 | 11.54 BRL |
| 12/11/2025 | 11.64 BRL |
| 12/10/2025 | 11.49 BRL |
| 12/9/2025 | 11.51 BRL |
| 12/8/2025 | 11.59 BRL |
| 12/5/2025 | 11.45 BRL |
| 12/4/2025 | 11.89 BRL |
| 12/3/2025 | 11.78 BRL |
| 12/2/2025 | 11.78 BRL |
| 12/1/2025 | 11.80 BRL |
| 11/28/2025 | 11.60 BRL |
| 11/27/2025 | 11.53 BRL |
| 11/26/2025 | 11.55 BRL |
| 11/25/2025 | 11.56 BRL |
| 11/24/2025 | 11.51 BRL |
| 11/21/2025 | 11.25 BRL |
| 11/19/2025 | 11.33 BRL |
| 11/18/2025 | 11.43 BRL |
| 11/17/2025 | 11.65 BRL |
| 11/14/2025 | 11.83 BRL |
| 11/13/2025 | 11.95 BRL |
| 11/12/2025 | 12.11 BRL |
| 11/11/2025 | 12.32 BRL |
| 11/10/2025 | 12.10 BRL |
| 11/7/2025 | 12.11 BRL |
| 11/6/2025 | 11.98 BRL |
| 11/5/2025 | 11.72 BRL |
| 11/4/2025 | 12.78 BRL |
| 11/3/2025 | 12.93 BRL |
| 10/31/2025 | 12.73 BRL |
| 10/30/2025 | 12.83 BRL |
| 10/29/2025 | 13.00 BRL |
| 10/28/2025 | 12.93 BRL |
| 10/27/2025 | 13.09 BRL |
| 10/24/2025 | 13.04 BRL |
| 10/23/2025 | 13.05 BRL |
| 10/22/2025 | 13.15 BRL |
| 10/21/2025 | 13.31 BRL |
| 10/20/2025 | 13.12 BRL |
| 10/17/2025 | 13.28 BRL |
| 10/16/2025 | 13.20 BRL |
| 10/15/2025 | 13.37 BRL |
| 10/14/2025 | 13.24 BRL |
| 10/13/2025 | 13.34 BRL |
| 10/10/2025 | 13.20 BRL |
| 10/9/2025 | 13.30 BRL |
| 10/8/2025 | 13.37 BRL |
| 10/7/2025 | 13.46 BRL |
| 10/6/2025 | 13.36 BRL |
| 10/3/2025 | 13.10 BRL |
| 10/2/2025 | 13.11 BRL |
| 10/1/2025 | 13.31 BRL |
| 9/30/2025 | 13.24 BRL |
| 9/29/2025 | 13.14 BRL |
| 9/26/2025 | 13.12 BRL |
| 9/25/2025 | 12.90 BRL |
| 9/24/2025 | 13.15 BRL |
| 9/23/2025 | 13.16 BRL |
| 9/22/2025 | 13.06 BRL |
| 9/19/2025 | 13.23 BRL |
| 9/18/2025 | 13.14 BRL |
| 9/17/2025 | 13.26 BRL |
| 9/16/2025 | 13.27 BRL |
| 9/15/2025 | 13.27 BRL |
| 9/12/2025 | 13.48 BRL |
| 9/11/2025 | 13.41 BRL |
| 9/10/2025 | 13.44 BRL |
| 9/9/2025 | 13.43 BRL |
| 9/8/2025 | 13.31 BRL |
| 9/5/2025 | 13.55 BRL |
| 9/4/2025 | 13.23 BRL |
| 9/3/2025 | 13.18 BRL |
| 9/2/2025 | 12.99 BRL |
| 9/1/2025 | 13.13 BRL |
| 8/29/2025 | 13.16 BRL |
| 8/28/2025 | 13.09 BRL |
| 8/27/2025 | 13.03 BRL |
| 8/26/2025 | 12.99 BRL |
| 8/25/2025 | 13.02 BRL |
| 8/22/2025 | 13.00 BRL |
| 8/21/2025 | 12.94 BRL |
| 8/20/2025 | 12.91 BRL |
| 8/19/2025 | 12.86 BRL |
| 8/18/2025 | 13.00 BRL |
Odontoprev Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Odontoprev Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB BRL |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB BRL |
| EBITB BRL |
| EBIT MARGIN% |
| NET INCOMEB BRL |
| NET INCOME GROWTH% |
| DIVIDENDDIV.BRL |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 | 1.25 | 1.37 | 1.44 | 1.59 | 1.81 | 1.77 | 1.85 | 1.85 | 2.12 | 2.28 | 2.42 | 2.54 | 2.73 | 2.91 | 3.19 |
| 8.14 | 8.04 | 9.29 | 5.27 | 10.72 | 13.64 | -2.38 | 4.59 | 0.43 | 14.24 | 7.70 | 6.09 | 4.92 | 7.56 | 6.59 | 9.41 |
| 52.51 | 53.40 | 50.77 | 68.68 | 52.17 | 55.20 | 56.83 | 57.75 | 27.02 | 40.79 | 34.33 | 34.71 | 34.71 | 34.71 | 34.71 | 34.71 |
| 0.61 | 0.67 | 0.69 | 0.99 | 0.83 | 1.00 | 1.00 | 1.07 | 0.50 | 0.86 | 0.78 | 0.84 | 0.88 | 0.95 | 1.01 | 1.11 |
| 0.27 | 0.31 | 0.31 | -0.47 | 0.38 | 0.38 | 0.52 | 0.55 | 0.48 | 0.80 | 0.72 | 0.72 | 0.82 | 0.87 | 0.94 | 1.02 |
| 23.70 | 24.98 | 22.34 | -32.43 | 23.70 | 21.07 | 29.63 | 29.79 | 26.00 | 37.87 | 31.43 | 29.79 | 32.10 | 31.86 | 32.12 | 32.09 |
| 0.19 | 0.22 | 0.22 | 0.50 | 0.28 | 0.28 | 0.36 | 0.38 | 0.37 | 0.51 | 0.54 | 0.58 | 0.57 | 0.64 | 0.73 | 1.06 |
| 3.19 | 13.40 | -2.27 | 133.49 | -43.43 | – | 27.11 | 5.26 | -3.95 | 40.00 | 5.48 | 7.98 | -2.92 | 12.92 | 13.79 | 45.32 |
| – | – | – | – | – | – | – | – | – | 0.32 | 1.03 | – | 1.14 | 1.25 | 1.38 | – |
| – | – | – | – | – | – | – | – | – | – | 221.88 | – | – | 9.65 | 10.40 | – |
| 584.32 | 584.49 | 600.46 | 592.16 | 581.52 | 582.87 | 584.41 | 623.18 | 552.50 | 552.50 | 536.96 | 545.09 | 545.09 | 545.09 | 545.09 | 545.09 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Odontoprev generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Odontoprev retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Odontoprev's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Odontoprev has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Odontoprev's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Odontoprev stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Odontoprev Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Odontoprev business model & stock analysis
Odontoprev SWOT Analysis
Strengths
Odontoprev SA has a strong market presence and brand recognition in the dental insurance industry.
The company has a wide network of dentists and healthcare providers, ensuring easy access to dental care services for its customers.
Odontoprev SA's commitment to quality care and customer satisfaction has resulted in a loyal customer base.
Weaknesses
Odontoprev SA is highly dependent on the Brazilian market, making it vulnerable to economic fluctuations and regulatory changes in the country.
The company may face challenges in differentiating itself from competitors in terms of pricing and service offerings.
Odontoprev SA's reliance on third-party healthcare providers may lead to limitations in service availability or quality control.
Opportunities
The growing demand for dental insurance and preventive dental care presents significant opportunities for Odontoprev SA.
Expanding into new geographic regions or offering innovative and specialized dental insurance products can help the company capture untapped market segments.
Collaborating with dental professionals and technology companies to leverage digital solutions can enhance customer experience and operational efficiency.
Threats
Intense competition within the dental insurance industry poses a threat to Odontoprev SA's market share and profitability.
Changes in government regulations related to healthcare policies and insurance may impact Odontoprev SA's business operations.
Economic downturns can lead to decreased consumer spending on dental insurance, affecting Odontoprev SA's revenue.
Odontoprev Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Odontoprev historical P/E ratio, EBIT multiple, and P/S ratio
Odontoprev annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Odontoprev shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Odontoprev stock splits
Odontoprev Dividend History
19 years of dividend payments
Odontoprev dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Odontoprev dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Odontoprev forecasts and price targets in August 2026
Analyst Price Targets 2026Odontoprev Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 5/8/2024 | 0.30BRL | - | 572.82 MBRL | - | 2024 Q1 |
| 2/28/2024 | 0.23BRL | - | 570.24 MBRL | - | 2023 Q4 |
| 7/25/2023 | 0.18BRL | - | 519.03 MBRL | - | 2023 Q2 |
| 4/25/2023 | 0.21BRL | - | 509.84 MBRL | - | 2023 Q1 |
| 2/21/2023 | 0.18BRL | - | 496.73 MBRL | - | 2022 Q4 |
| 10/26/2022 | 0.18BRL | - | 498.53 MBRL | - | 2022 Q3 |
| 7/27/2022 | 0.19BRL | - | 488.55 MBRL | - | 2022 Q2 |
| 4/27/2022 | 0.16BRL | - | 493.34 MBRL | - | 2022 Q1 |
| 2/23/2022 | 0.15BRL | - | 474.03 MBRL | - | 2021 Q4 |
| 10/27/2021 | 0.15BRL | - | 456.19 MBRL | - | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Odontoprev stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Odontoprev shareholder structure
| % | Name |
|---|---|
53.44491% | |
4.81305% | |
2.86723% | |
2.26792% | |
1.57194% | |
1.55035% |
Odontoprev Beneficial Ownership Filings (SEC 13D/G)
Odontoprev Executives and Management Board
14 members · avg. age 61 · 14 % women
Management
Mr. Elsen Carvalho (50)
Chief Executive Officer, Commercial Director, Member of the Executive Board
Mr. Jose Roberto Borges Pacheco (62)
Chief Financial Officer, Investor Relations Officer, Member of the Executive Board · since 2023
Mr. Andre De Franca
Legal, Compliance Officer, DPO and Corporate Governance Officer, Member of the Executive Board
Board of Directors
Mr. Luiz Carlos Trabuco Cappi (73)
Chairman of the Board · since 2009
Mr. Manoel Antonio Peres (60)
Vice Chairman of the Board
Ms. Rose Gabay (59)
Human Resources Director, Member of the Executive Board
Mr. Renato Alves Costa (36)
IT, Marketing and Sustainability Director, Member of the Executive Board · since 2023
Mr. Marcos Pimentel de Viveiros (51)
Customer Service, New Business and Products Director, Member of the Executive Board · since 2023
Mr. Octavio de Lazari (61)
Director
Frequently asked questions about Odontoprev
Odontoprev SA operates with a business model focused on providing dental services and oral health care plans in Brazil. The company's main objective is to offer affordable and quality dental care to individuals and corporate clients through its extensive network of dental providers. Odontoprev SA works closely with dentists, clinics, and laboratories to ensure access to a wide range of dental treatments, preventive care, and specialized services. By offering comprehensive dental plans, the company aims to promote oral health and contribute to improved overall well-being in the communities it serves.
Odontoprev SA is primarily active in the dental insurance industry.
The main competitors of Odontoprev SA in the market include Qualicorp SA, SulAmérica SA, and Bradesco Seguros SA.
Odontoprev SA is a reputable company in the dental care industry. Established in 1987, Odontoprev SA has been a leading provider of oral health services in Brazil. The company has a strong commitment to improving access to quality dental care and promoting oral health awareness. With a vast network of dentists and partnerships with insurance companies, Odontoprev SA offers a comprehensive range of dental plans and services, ensuring the satisfaction of its customers. Over the years, Odontoprev SA has consistently shown dedication to innovation, customer-centricity, and excellence, making it a trusted name in the dental care sector.
Odontoprev SA has achieved significant milestones throughout its history. As a leading dental benefits provider in Brazil, the company has constantly focused on expanding its reach and improving its services. Odontoprev SA has successfully established a strong network of dentists and clinics, ensuring accessibility and quality dental care for its members. Additionally, the company has demonstrated consistent growth and financial performance, gaining recognition as a reliable investment opportunity. With its commitment to providing affordable and comprehensive oral health plans, Odontoprev SA has become a trusted name in the industry, catering to the dental needs of numerous individuals and organizations in Brazil.
Odontoprev SA is primarily present in Brazil.
Odontoprev SA represents a strong commitment to values and a clear corporate philosophy. The company's core values include integrity, transparency, and excellence in service provision. Odontoprev SA believes in delivering high-quality dental care and promoting oral health for individuals and businesses. With a customer-centric approach, the company prioritizes ethical business practices and ensures customer satisfaction. Odontoprev SA continuously invests in technology, innovation, and professional development to stay at the forefront of the industry. By upholding these values and corporate philosophy, Odontoprev SA establishes itself as a reliable and trustworthy provider in the dental care sector.
Analysts currently set an average price target of 12.82 BRL for the Odontoprev stock (median: 13.26 BRL), implying -12.3 % versus the latest price. The consensus is based on 17 analyst ratings.
17 analysts currently rate the Odontoprev stock: 1 recommend buying, 8 holding and 8 selling. For 2026, analysts expect Odontoprev to generate revenue of 2.54 B BRL and earnings per share of 1.04 BRL.
Converted at the current exchange rate, the Odontoprev share trades at 2.43 EUR (14.62 BRL).
Odontoprev SA is the largest dental insurance provider in Latin America and offers a wide range of dental services and free consultation services to its customers. The company was founded in Brazil in 1987 and has since become a major player in the health market. The company operates in two main business areas: dental insurance and dental services. Odontoprev's dental insurance is unique and offers individual and flexible rates and plans tailored to the needs and budgets of each customer. The plans offer a wide range of dental services, including prophylaxis, teeth whitening, orthodontics, and jaw surgery. In addition, Odontoprev also offers an extensive network of dentists who collaborate with the company. These dentists are accessible to the company's customers in all regions of the country and offer high-quality dental services at affordable prices. Odontoprev stands out from the competition through its focus on high-quality dental services and innovation. The company works closely with its partner dentists to ensure that the latest and best technologies and methods are available to its customers. To provide even better services to its customers, the company has developed an app that helps customers manage their dental care. The app allows users to schedule appointments, submit insurance claims, manage their accounts, and receive advice and tips for better oral health. Odontoprev has experienced rapid growth in recent years and has established itself as a leading provider of dental insurance and dental services in the region. The company now serves hundreds of thousands of customers in Brazil and other Latin American countries, and its growth shows no signs of slowing down. In summary, Odontoprev is an innovative company that offers high-quality dental care and services at affordable prices. The company is well-positioned to continue growing in the coming years and play a significant role in the health market in Latin America.
The expected revenue of Odontoprev is 2.54 B BRL. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Odontoprev is 565.24 M BRL. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Odontoprev is currently 14.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Odontoprev stock.
The price-to-sales ratio (P/S) of Odontoprev is currently 3.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Odontoprev stock.
The Eulerpool Quality Score for Odontoprev is 7/10.
The ISIN of Odontoprev is BRODPVACNOR4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Odontoprev is ODPV3.SA. The ticker symbol is used to trade Odontoprev shares on the stock exchange.
Over the past 12 months, Odontoprev paid a dividend of 0.96 BRL . This corresponds to a dividend yield of about 6.58 %. For the coming 12 months, Odontoprev is expected to pay a dividend of 1.25 BRL.
The current dividend yield of Odontoprev is 6.58 %.
Odontoprev pays a dividend, distributed in the months of , , , .
Odontoprev paid dividends every year for the past 19 years.
For the upcoming 12 months, dividends amounting to 1.25 BRL are expected. This corresponds to a dividend yield of 8.56 %.
Odontoprev is assigned to the 'Health' sector.
To receive the latest dividend of Odontoprev from amounting to 0.24 BRL, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Odontoprev distributed 1.03 BRL as dividends.
The dividends of Odontoprev are distributed in BRL.
Odontoprev stock
Odontoprev Peer Group
Odontoprev Ticker
Odontoprev FIGI
All fundamentals and in-depth analysis of Odontoprev
Our stock analysis for Odontoprev stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Odontoprev. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.